跳至主要内容
临床试验/EUCTR2004-000441-38-IE
EUCTR2004-000441-38-IE进行中(未招募)1 期

arge, Simple Trial Comparing Two Strategies for Management of Anti-Retroviral Therapy (The SMART Study) - SMART

ational Institute of Allergy and Infectious Diseases, National Institutes of Health0 个研究点目标入组 6,000 人开始时间: 2006年11月24日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
6,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Signed informed consent
  • 2. Evidence of HIV infection (positive ELISA and Western Blot and/or documented history of measurable HIV RNA)
  • 3. Age > 13 years (in effect 18 years in Ireland and UK sites)
  • 4. Current CD4+ cell count > 350 cells/mm3 (within 45 days prior to randomization)
  • 5. Willing to initiate, modify, or stop antiretroviral therapy, in accordance with the randomized assignment
  • 6. If participating in sexual activity that could lead to pregnancy, willingness to use acceptable contraception methods
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1. Current participation in the CPCRA FIRST, MDR-HIV or another study which is not consistent with one of the treatment groups in the SMART study (e.g., ESPRIT or SILCAAT).
  • 2. Current pregnancy or breastfeeding

研究者

发起方
ational Institute of Allergy and Infectious Diseases, National Institutes of Health

相似试验

arge, Simple Trial Comparing Two Strategies for... | 临床试验